Alexion Pharmaceuticals INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoston, MA
US patents195
SAM.gov UEIDKCXLGANZAN3
CAGE code4EXK1
Incorporated inDE
LEIM1YXUUZR0EIMU8T0EM75
Brands
This company sells these brands.
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
195 US patents granted 1996–2025, 74 of them in the five years to SEP 2025.
Pharmaceuticals 132Biotechnology 25Measurement 23Organic fine chemistry 5Medical technology 3
- Anti-ALK2 antibodies and uses thereofUS 12,428,484 · granted SEP 30, 2025
- Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patientsUS 12,404,320 · granted SEP 2, 2025
- Compositions and methods for preparing factor Xa and derivativesUS 12,398,387 · granted AUG 26, 2025
- Cerdulatinib for the treatment of b-cell malignanciesUS 12,350,269 · granted JUL 8, 2025
- Methods of producing anti-C5 antibodiesUS 12,312,394 · granted MAY 27, 2025
Newest 5 shown · Granted to Alexion Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Alexion Pharmaceuticals INC | Boston | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.








